The outcomes after LT for patients with liver cirrhosis and HCV depend on variables related not only to the transplantation, such as organ availability, donor selection, allocation strategies, liver disease severity, and local expertise but also on factors associated with HCC survival, such as AFP levels and tumor characteristics. Here, AFP is linked to hepatocellular carcinoma.